Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

Similar articles for PubMed (Select 23026707)

1.

Factors modifying transcriptional regulation of signaling genes have putative role in tumor development and progression in humans.

Qidwai MT, Jamal F, Singh D, Sharma RK.

Med Hypotheses. 2012 Dec;79(6):805-12. doi: 10.1016/j.mehy.2012.08.033. Epub 2012 Sep 29.

PMID:
23026707
4.

Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer?

Van Seuningen I, Pigny P, Perrais M, Porchet N, Aubert JP.

Front Biosci. 2001 Oct 1;6:D1216-34. Review.

PMID:
11578973
6.

CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site.

Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W, Archer TK.

Oncogene. 1998 Mar 5;16(9):1161-9.

7.

hCTR9, a component of Paf1 complex, participates in the transcription of interleukin 6-responsive genes through regulation of STAT3-DNA interactions.

Youn MY, Yoo HS, Kim MJ, Hwang SY, Choi Y, Desiderio SV, Yoo JY.

J Biol Chem. 2007 Nov 30;282(48):34727-34. Epub 2007 Oct 1.

8.

Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer.

Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG.

Hum Mol Genet. 2001 Apr;10(7):687-92. Review.

9.

Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.

Zaia A, Fraizer GC, Piantanelli L, Saunders GF.

Anticancer Res. 2001 Jan-Feb;21(1A):1-10.

PMID:
11299720
10.
13.

Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer.

Kinoshita H, Shi Y, Sandefur C, Meisner LF, Chang C, Choon A, Reznikoff CR, Bova GS, Friedl A, Jarrard DF.

Cancer Res. 2000 Jul 1;60(13):3623-30.

14.

The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins.

Schumann RR, Kirschning CJ, Unbehaun A, Aberle HP, Knope HP, Lamping N, Ulevitch RJ, Herrmann F.

Mol Cell Biol. 1996 Jul;16(7):3490-503.

15.

LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer.

Abdollahi A, Pisarcik D, Roberts D, Weinstein J, Cairns P, Hamilton TC.

J Biol Chem. 2003 Feb 21;278(8):6041-9. Epub 2002 Dec 6.

16.
17.

Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer.

Eisermann K, Tandon S, Bazarov A, Brett A, Fraizer G, Piontkivska H.

BMC Genomics. 2008 Jul 16;9:337. doi: 10.1186/1471-2164-9-337.

18.

Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation.

Ghoshal K, Majumder S, Li Z, Dong X, Jacob ST.

J Biol Chem. 2000 Jan 7;275(1):539-47.

19.

Transcriptional regulation of the junB promoter: analysis of STAT-mediated signal transduction.

Coffer P, Lutticken C, van Puijenbroek A, Klop-de Jonge M, Horn F, Kruijer W.

Oncogene. 1995 Mar 2;10(5):985-94.

PMID:
7898939
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk